Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy

Clinical trial NCT00344617 · UNKNOWN

Trial details

NCT number: NCT00344617
Sponsor: Singapore National Eye Centre
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Choroidal Neovascularisation Polypoidal Choroidal Vasculopathy

Start date: 2006-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.